Valent BioSciences LLC announced that it is undertaking two major environmental initiatives at its biorational manufacturing facility in Osage, Iowa. They include a new...
Abiomed announces the successful results of the first-in-human early feasibility study of the preCARDIA system. The preCARDIA system is designed to improve decongestion in...
Fusion Pharmaceuticals Inc., a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, announced nomination of the first targeted alpha therapy (TAT)...
Pharmaron Beijing Co., Limited announced that it has acquired Aesica Pharmaceuticals Limited (“The Cramlington Site”) from Recipharm group.
Also Read: Washington State Department of Health...
Takeda Pharmaceutical Company Limited (“Takeda”) announced the exercise of its option to acquire Adaptate Biotherapeutics (“Adaptate”), a UK company focused on developing antibody-based therapeutics...
